Global Neuroprotective Agents Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Neuroprotective Agents Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Neuroprotective Agents by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Neuroprotective Agents by Country/Region, 2017, 2022 & 2028

2.2 Neuroprotective Agents Segment by Type

2.2.1 Cerebrovascular Diseases

2.2.2 Neurodegenerative Disorders

2.2.3 Ophthalmic Diseases

2.2.4 Traumatic CNS Injuries

2.3 Neuroprotective Agents Sales by Type

2.3.1 Global Neuroprotective Agents Sales Market Share by Type (2017-2022)

2.3.2 Global Neuroprotective Agents Revenue and Market Share by Type (2017-2022)

2.3.3 Global Neuroprotective Agents Sale Price by Type (2017-2022)

2.4 Neuroprotective Agents Segment by Application

2.4.1 Hospitals

2.4.2 Clinics

2.4.3 Others

2.5 Neuroprotective Agents Sales by Application

2.5.1 Global Neuroprotective Agents Sale Market Share by Application (2017-2022)

2.5.2 Global Neuroprotective Agents Revenue and Market Share by Application (2017-2022)

2.5.3 Global Neuroprotective Agents Sale Price by Application (2017-2022)

3 Global Neuroprotective Agents by Company

3.1 Global Neuroprotective Agents Breakdown Data by Company

3.1.1 Global Neuroprotective Agents Annual Sales by Company (2020-2022)

3.1.2 Global Neuroprotective Agents Sales Market Share by Company (2020-2022)

3.2 Global Neuroprotective Agents Annual Revenue by Company (2020-2022)

3.2.1 Global Neuroprotective Agents Revenue by Company (2020-2022)

3.2.2 Global Neuroprotective Agents Revenue Market Share by Company (2020-2022)

3.3 Global Neuroprotective Agents Sale Price by Company

3.4 Key Manufacturers Neuroprotective Agents Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Neuroprotective Agents Product Location Distribution

3.4.2 Players Neuroprotective Agents Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Neuroprotective Agents by Geographic Region

4.1 World Historic Neuroprotective Agents Market Size by Geographic Region (2017-2022)

4.1.1 Global Neuroprotective Agents Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Neuroprotective Agents Annual Revenue by Geographic Region

4.2 World Historic Neuroprotective Agents Market Size by Country/Region (2017-2022)

4.2.1 Global Neuroprotective Agents Annual Sales by Country/Region (2017-2022)

4.2.2 Global Neuroprotective Agents Annual Revenue by Country/Region

4.3 Americas Neuroprotective Agents Sales Growth

4.4 APAC Neuroprotective Agents Sales Growth

4.5 Europe Neuroprotective Agents Sales Growth

4.6 Middle East & Africa Neuroprotective Agents Sales Growth

5 Americas

5.1 Americas Neuroprotective Agents Sales by Country

5.1.1 Americas Neuroprotective Agents Sales by Country (2017-2022)

5.1.2 Americas Neuroprotective Agents Revenue by Country (2017-2022)

5.2 Americas Neuroprotective Agents Sales by Type

5.3 Americas Neuroprotective Agents Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Neuroprotective Agents Sales by Region

6.1.1 APAC Neuroprotective Agents Sales by Region (2017-2022)

6.1.2 APAC Neuroprotective Agents Revenue by Region (2017-2022)

6.2 APAC Neuroprotective Agents Sales by Type

6.3 APAC Neuroprotective Agents Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Neuroprotective Agents by Country

7.1.1 Europe Neuroprotective Agents Sales by Country (2017-2022)

7.1.2 Europe Neuroprotective Agents Revenue by Country (2017-2022)

7.2 Europe Neuroprotective Agents Sales by Type

7.3 Europe Neuroprotective Agents Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Neuroprotective Agents by Country

8.1.1 Middle East & Africa Neuroprotective Agents Sales by Country (2017-2022)

8.1.2 Middle East & Africa Neuroprotective Agents Revenue by Country (2017-2022)

8.2 Middle East & Africa Neuroprotective Agents Sales by Type

8.3 Middle East & Africa Neuroprotective Agents Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Neuroprotective Agents

10.3 Manufacturing Process Analysis of Neuroprotective Agents

10.4 Industry Chain Structure of Neuroprotective Agents

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Neuroprotective Agents Distributors

11.3 Neuroprotective Agents Customer

12 World Forecast Review for Neuroprotective Agents by Geographic Region

12.1 Global Neuroprotective Agents Market Size Forecast by Region

12.1.1 Global Neuroprotective Agents Forecast by Region (2023-2028)

12.1.2 Global Neuroprotective Agents Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Neuroprotective Agents Forecast by Type

12.7 Global Neuroprotective Agents Forecast by Application

13 Key Players Analysis

13.1 Genervon Biopharmaceuticals

13.1.1 Genervon Biopharmaceuticals Company Information

13.1.2 Genervon Biopharmaceuticals Neuroprotective Agents Product Offered

13.1.3 Genervon Biopharmaceuticals Neuroprotective Agents Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Genervon Biopharmaceuticals Main Business Overview

13.1.5 Genervon Biopharmaceuticals Latest Developments

13.2 NeuroVive Pharmaceutical

13.2.1 NeuroVive Pharmaceutical Company Information

13.2.2 NeuroVive Pharmaceutical Neuroprotective Agents Product Offered

13.2.3 NeuroVive Pharmaceutical Neuroprotective Agents Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 NeuroVive Pharmaceutical Main Business Overview

13.2.5 NeuroVive Pharmaceutical Latest Developments

13.3 Ceregene

13.3.1 Ceregene Company Information

13.3.2 Ceregene Neuroprotective Agents Product Offered

13.3.3 Ceregene Neuroprotective Agents Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Ceregene Main Business Overview

13.3.5 Ceregene Latest Developments

13.4 Neuren Pharmaceuticals

13.4.1 Neuren Pharmaceuticals Company Information

13.4.2 Neuren Pharmaceuticals Neuroprotective Agents Product Offered

13.4.3 Neuren Pharmaceuticals Neuroprotective Agents Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Neuren Pharmaceuticals Main Business Overview

13.4.5 Neuren Pharmaceuticals Latest Developments

13.5 Allon Therapeutics

13.5.1 Allon Therapeutics Company Information

13.5.2 Allon Therapeutics Neuroprotective Agents Product Offered

13.5.3 Allon Therapeutics Neuroprotective Agents Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Allon Therapeutics Main Business Overview

13.5.5 Allon Therapeutics Latest Developments

14 Research Findings and Conclusion

Table 1. Neuroprotective Agents Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Neuroprotective Agents Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Cerebrovascular Diseases

Table 4. Major Players of Neurodegenerative Disorders

Table 5. Major Players of Ophthalmic Diseases

Table 6. Major Players of Traumatic CNS Injuries

Table 7. Global Neuroprotective Agents Sales by Type (2017-2022) & (K MT)

Table 8. Global Neuroprotective Agents Sales Market Share by Type (2017-2022)

Table 9. Global Neuroprotective Agents Revenue by Type (2017-2022) & ($ million)

Table 10. Global Neuroprotective Agents Revenue Market Share by Type (2017-2022)

Table 11. Global Neuroprotective Agents Sale Price by Type (2017-2022) & (USD/MT)

Table 12. Global Neuroprotective Agents Sales by Application (2017-2022) & (K MT)

Table 13. Global Neuroprotective Agents Sales Market Share by Application (2017-2022)

Table 14. Global Neuroprotective Agents Revenue by Application (2017-2022)

Table 15. Global Neuroprotective Agents Revenue Market Share by Application (2017-2022)

Table 16. Global Neuroprotective Agents Sale Price by Application (2017-2022) & (USD/MT)

Table 17. Global Neuroprotective Agents Sales by Company (2020-2022) & (K MT)

Table 18. Global Neuroprotective Agents Sales Market Share by Company (2020-2022)

Table 19. Global Neuroprotective Agents Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Neuroprotective Agents Revenue Market Share by Company (2020-2022)

Table 21. Global Neuroprotective Agents Sale Price by Company (2020-2022) & (USD/MT)

Table 22. Key Manufacturers Neuroprotective Agents Producing Area Distribution and Sales Area

Table 23. Players Neuroprotective Agents Products Offered

Table 24. Neuroprotective Agents Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Neuroprotective Agents Sales by Geographic Region (2017-2022) & (K MT)

Table 28. Global Neuroprotective Agents Sales Market Share Geographic Region (2017-2022)

Table 29. Global Neuroprotective Agents Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Neuroprotective Agents Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Neuroprotective Agents Sales by Country/Region (2017-2022) & (K MT)

Table 32. Global Neuroprotective Agents Sales Market Share by Country/Region (2017-2022)

Table 33. Global Neuroprotective Agents Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Neuroprotective Agents Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Neuroprotective Agents Sales by Country (2017-2022) & (K MT)

Table 36. Americas Neuroprotective Agents Sales Market Share by Country (2017-2022)

Table 37. Americas Neuroprotective Agents Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Neuroprotective Agents Revenue Market Share by Country (2017-2022)

Table 39. Americas Neuroprotective Agents Sales by Type (2017-2022) & (K MT)

Table 40. Americas Neuroprotective Agents Sales Market Share by Type (2017-2022)

Table 41. Americas Neuroprotective Agents Sales by Application (2017-2022) & (K MT)

Table 42. Americas Neuroprotective Agents Sales Market Share by Application (2017-2022)

Table 43. APAC Neuroprotective Agents Sales by Region (2017-2022) & (K MT)

Table 44. APAC Neuroprotective Agents Sales Market Share by Region (2017-2022)

Table 45. APAC Neuroprotective Agents Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Neuroprotective Agents Revenue Market Share by Region (2017-2022)

Table 47. APAC Neuroprotective Agents Sales by Type (2017-2022) & (K MT)

Table 48. APAC Neuroprotective Agents Sales Market Share by Type (2017-2022)

Table 49. APAC Neuroprotective Agents Sales by Application (2017-2022) & (K MT)

Table 50. APAC Neuroprotective Agents Sales Market Share by Application (2017-2022)

Table 51. Europe Neuroprotective Agents Sales by Country (2017-2022) & (K MT)

Table 52. Europe Neuroprotective Agents Sales Market Share by Country (2017-2022)

Table 53. Europe Neuroprotective Agents Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Neuroprotective Agents Revenue Market Share by Country (2017-2022)

Table 55. Europe Neuroprotective Agents Sales by Type (2017-2022) & (K MT)

Table 56. Europe Neuroprotective Agents Sales Market Share by Type (2017-2022)

Table 57. Europe Neuroprotective Agents Sales by Application (2017-2022) & (K MT)

Table 58. Europe Neuroprotective Agents Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Neuroprotective Agents Sales by Country (2017-2022) & (K MT)

Table 60. Middle East & Africa Neuroprotective Agents Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Neuroprotective Agents Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Neuroprotective Agents Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Neuroprotective Agents Sales by Type (2017-2022) & (K MT)

Table 64. Middle East & Africa Neuroprotective Agents Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Neuroprotective Agents Sales by Application (2017-2022) & (K MT)

Table 66. Middle East & Africa Neuroprotective Agents Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Neuroprotective Agents

Table 68. Key Market Challenges & Risks of Neuroprotective Agents

Table 69. Key Industry Trends of Neuroprotective Agents

Table 70. Neuroprotective Agents Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Neuroprotective Agents Distributors List

Table 73. Neuroprotective Agents Customer List

Table 74. Global Neuroprotective Agents Sales Forecast by Region (2023-2028) & (K MT)

Table 75. Global Neuroprotective Agents Sales Market Forecast by Region

Table 76. Global Neuroprotective Agents Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Neuroprotective Agents Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Neuroprotective Agents Sales Forecast by Country (2023-2028) & (K MT)

Table 79. Americas Neuroprotective Agents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Neuroprotective Agents Sales Forecast by Region (2023-2028) & (K MT)

Table 81. APAC Neuroprotective Agents Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Neuroprotective Agents Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Europe Neuroprotective Agents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Neuroprotective Agents Sales Forecast by Country (2023-2028) & (K MT)

Table 85. Middle East & Africa Neuroprotective Agents Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Neuroprotective Agents Sales Forecast by Type (2023-2028) & (K MT)

Table 87. Global Neuroprotective Agents Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Neuroprotective Agents Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Neuroprotective Agents Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Neuroprotective Agents Sales Forecast by Application (2023-2028) & (K MT)

Table 91. Global Neuroprotective Agents Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Neuroprotective Agents Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Neuroprotective Agents Revenue Market Share Forecast by Application (2023-2028)

Table 94. Genervon Biopharmaceuticals Basic Information, Neuroprotective Agents Manufacturing Base, Sales Area and Its Competitors

Table 95. Genervon Biopharmaceuticals Neuroprotective Agents Product Offered

Table 96. Genervon Biopharmaceuticals Neuroprotective Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 97. Genervon Biopharmaceuticals Main Business

Table 98. Genervon Biopharmaceuticals Latest Developments

Table 99. NeuroVive Pharmaceutical Basic Information, Neuroprotective Agents Manufacturing Base, Sales Area and Its Competitors

Table 100. NeuroVive Pharmaceutical Neuroprotective Agents Product Offered

Table 101. NeuroVive Pharmaceutical Neuroprotective Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 102. NeuroVive Pharmaceutical Main Business

Table 103. NeuroVive Pharmaceutical Latest Developments

Table 104. Ceregene Basic Information, Neuroprotective Agents Manufacturing Base, Sales Area and Its Competitors

Table 105. Ceregene Neuroprotective Agents Product Offered

Table 106. Ceregene Neuroprotective Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 107. Ceregene Main Business

Table 108. Ceregene Latest Developments

Table 109. Neuren Pharmaceuticals Basic Information, Neuroprotective Agents Manufacturing Base, Sales Area and Its Competitors

Table 110. Neuren Pharmaceuticals Neuroprotective Agents Product Offered

Table 111. Neuren Pharmaceuticals Neuroprotective Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 112. Neuren Pharmaceuticals Main Business

Table 113. Neuren Pharmaceuticals Latest Developments

Table 114. Allon Therapeutics Basic Information, Neuroprotective Agents Manufacturing Base, Sales Area and Its Competitors

Table 115. Allon Therapeutics Neuroprotective Agents Product Offered

Table 116. Allon Therapeutics Neuroprotective Agents Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 117. Allon Therapeutics Main Business

Table 118. Allon Therapeutics Latest Developments

List of Figures

Figure 1. Picture of Neuroprotective Agents

Figure 2. Neuroprotective Agents Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Neuroprotective Agents Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Neuroprotective Agents Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Neuroprotective Agents Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Cerebrovascular Diseases

Figure 10. Product Picture of Neurodegenerative Disorders

Figure 11. Product Picture of Ophthalmic Diseases

Figure 12. Product Picture of Traumatic CNS Injuries

Figure 13. Global Neuroprotective Agents Sales Market Share by Type in 2021

Figure 14. Global Neuroprotective Agents Revenue Market Share by Type (2017-2022)

Figure 15. Neuroprotective Agents Consumed in Hospitals

Figure 16. Global Neuroprotective Agents Market: Hospitals (2017-2022) & (K MT)

Figure 17. Neuroprotective Agents Consumed in Clinics

Figure 18. Global Neuroprotective Agents Market: Clinics (2017-2022) & (K MT)

Figure 19. Neuroprotective Agents Consumed in Others

Figure 20. Global Neuroprotective Agents Market: Others (2017-2022) & (K MT)

Figure 21. Global Neuroprotective Agents Sales Market Share by Application (2017-2022)

Figure 22. Global Neuroprotective Agents Revenue Market Share by Application in 2021

Figure 23. Neuroprotective Agents Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Neuroprotective Agents Revenue Market Share by Company in 2021

Figure 25. Global Neuroprotective Agents Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Neuroprotective Agents Revenue Market Share by Geographic Region in 2021

Figure 27. Global Neuroprotective Agents Sales Market Share by Region (2017-2022)

Figure 28. Global Neuroprotective Agents Revenue Market Share by Country/Region in 2021

Figure 29. Americas Neuroprotective Agents Sales 2017-2022 (K MT)

Figure 30. Americas Neuroprotective Agents Revenue 2017-2022 ($ Millions)

Figure 31. APAC Neuroprotective Agents Sales 2017-2022 (K MT)

Figure 32. APAC Neuroprotective Agents Revenue 2017-2022 ($ Millions)

Figure 33. Europe Neuroprotective Agents Sales 2017-2022 (K MT)

Figure 34. Europe Neuroprotective Agents Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Neuroprotective Agents Sales 2017-2022 (K MT)

Figure 36. Middle East & Africa Neuroprotective Agents Revenue 2017-2022 ($ Millions)

Figure 37. Americas Neuroprotective Agents Sales Market Share by Country in 2021

Figure 38. Americas Neuroprotective Agents Revenue Market Share by Country in 2021

Figure 39. United States Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Neuroprotective Agents Sales Market Share by Region in 2021

Figure 44. APAC Neuroprotective Agents Revenue Market Share by Regions in 2021

Figure 45. China Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Neuroprotective Agents Sales Market Share by Country in 2021

Figure 52. Europe Neuroprotective Agents Revenue Market Share by Country in 2021

Figure 53. Germany Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Neuroprotective Agents Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Neuroprotective Agents Revenue Market Share by Country in 2021

Figure 60. Egypt Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Neuroprotective Agents Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Neuroprotective Agents in 2021

Figure 66. Manufacturing Process Analysis of Neuroprotective Agents

Figure 67. Industry Chain Structure of Neuroprotective Agents

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles